Search
mobile logo
Title Image

LSKB Attending Bio Europe Spring in Stockholm

WRITTEN BY:

RELATED POSTS

Elevar Therapeutics Acquires Global Rights to European Approved Apealea® from Oasmia Pharmaceutical
Elevar Therapeutics Announces Enrollment of the First Patient in a Pivotal Trial for the Treatment of Adenoid Cystic Cancer (ACC)
Elevar Announces Results from the ANGEL trial, a study of Monotherapy Rivoceranib (Apatinib) in Late-Stage Gastric Cancer Patients
Elevar Therapeutics Announces Appointment of New Member to the Board of Directors
South San Francisco U.S.

400 Oyster Point Blvd, Suite 214
South San Francisco, CA 94080
U.S.A.

Salt Lake City U.S. [Headquarters]

2825 E Cottonwood Pkwy Suite 180,
Salt Lake City, UT 84121
U.S.A.

Phone: 801-303-7440
Fax: 801-303-7455

South Korea

7F Mayple Tower, Teheran-ro 420,
Gangnam-gu, Seoul 06193
Republic of Korea

Ireland

The Black Church,
St Mary’s Place,
Dublin, D07 P4AX,
Ireland

Phone: 353-1-969-6739
Fax: 353-1-685-3040

© Copyright 2020 Elevar Therapeutics